Abstract:The trisaccharide b-dGlcNAc(1 32)a-d-Man(1 33)d-Man is a fragment of a biantennary glycan that is recognized by a-d-Man-specific lectins such as concanavalin A (ConA), Lathyrus ochrus lectin, lentil lectin, and can adopt several conformations upon binding. To probe the importance of loss of flexibility of a saccharide during binding with ConA this trisaccharide has been synthesized in a conformationally constrained form where a methylene acetal bridge mimics a GlcNAc ± O-6''´´´Man ± O-4 intramolecular hydrogen bond. Microcalorimetry measurements revealed that the conformationally constrained compound has a more favorable entropy term but this term is offset by a smaller enthalpy term. NMR spectroscopic studies have shown that the cyclic compound is indeed considerably less flexible than the linear compound and both compounds adopt mainly one conformation. SYBYL software together with energy parameters appropriate for carbohydrates was used for a systematic conformational search. The linear compound is very flexible. A clustering method determined seven main conformational families. Six possible conformational families were identified for the cyclic compound when considering the orientations of the bGlcNAc(1 32)Man and abMan-(1 33)Man glycosidic bonds. The central mannose residue was docked in the binding site of ConA and the complex was refined. The results are compared with crystal structures of legume lectin ± oligosaccharide complexes and with the NMR and thermodynamic data.
Synthesis of Benzimidazole (IV) and Pyrrolo(2,3-d)pyrimidine Analogues (IX) of "iso-2',3'-Dideoxyadenosine" (iso-ddA).--(NAVARRE, N.; PRESTON, P. N.; TSYTOVICH, A. V.; WIGHTMAN, R. H.;
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.